Literature DB >> 20872725

Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene.

Iana H Haralambieva1, Inna G Ovsyannikova, Neelam Dhiman, Robert A Vierkant, Robert M Jacobson, Gregory A Poland.   

Abstract

The measles virus phosphoprotein (P) gene encodes the P, V, and C proteins, which have multiple functions including type I interferon (IFN) inhibition. With a focus on viral immune modulation, we conducted a study on healthy vaccinees (n=179) to compare cytokine secretion patterns/cell frequencies and gene expression after in vitro encounter with a highly attenuated strain of measles virus (MVEdmtag), wild-type MV (MVwt) or recombinant MVEdmtag expressing the wild-type P gene (MVwtP). Cytokines were quantified by ELISA and Elispot. Gene expression profiling was performed using real-time PCR. We found differential MV-specific cytokine responses to all detected cytokines characterized by significantly higher cytokine levels (P<0.001) and higher frequencies (P<0.0001) of cytokine-producing cells after stimulation with the highly attenuated MVEdmtag strain in comparison with MVwt or MVwtP. Furthermore, gene expression profiling revealed significant cytokine suppression at the transcriptional level for viruses encoding the functional wt P gene, compared to attenuated MVEdmtag (P<0.05). Using lentivirus-mediated stable expression of P gene-encoded proteins in human cell lines, we demonstrated that the expression of the functional wt V protein significantly down-modulated the induction of IFNs type I, II, and III in lymphocytes and monocytes. Taken together our results indicate that Th1, Th2, and innate/inflammatory cytokine responses in vaccinees are suppressed both at the protein and transcriptional level by viruses expressing the functional wt P gene products. The functional P gene-encoded viral proteins (particularly V proteins) emerge as crucial immune evasion factors for modulating and shaping the measles virus-specific cytokine responses in humans.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872725      PMCID: PMC3924428          DOI: 10.1002/jmv.21899

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  54 in total

Review 1.  Type 1 interferons and the virus-host relationship: a lesson in détente .

Authors:  Adolfo García-Sastre; Christine A Biron
Journal:  Science       Date:  2006-05-12       Impact factor: 47.728

Review 2.  Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression.

Authors:  Sibylle Schneider-Schaulies; Ulf Dittmer
Journal:  J Gen Virol       Date:  2006-06       Impact factor: 3.891

3.  Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.

Authors:  N Dhiman; I G Ovsyannikova; J E Ryan; R M Jacobson; R A Vierkant; V S Pankratz; S J Jacobsen; G A Poland
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

4.  The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines.

Authors:  Heidi Berghäll; Jukka Sirén; Devanand Sarkar; Ilkka Julkunen; Paul B Fisher; Raija Vainionpää; Sampsa Matikainen
Journal:  Microbes Infect       Date:  2006-05-26       Impact factor: 2.700

5.  Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-12-06       Impact factor: 2.846

Review 6.  Measles virus: cellular receptors, tropism and pathogenesis.

Authors:  Yusuke Yanagi; Makoto Takeda; Shinji Ohno
Journal:  J Gen Virol       Date:  2006-10       Impact factor: 3.891

7.  Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

8.  Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cells.

Authors:  J E Ryan; I G Ovsyannikova; N Dhiman; N A Pinsky; R A Vierkant; R M Jacobson; G A Poland
Journal:  Scand J Clin Lab Invest       Date:  2005       Impact factor: 1.713

9.  Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Yasushi Ami; Noriyo Nagata; Yuriko Suzaki; Jamila Shahnewaz; Shin-Ichi Kadota; Kyosuke Nagata
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

10.  Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens.

Authors:  Michael J Zilliox; Giovanni Parmigiani; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

View more
  8 in total

1.  Associations between demographic variables and multiple measles-specific innate and cell-mediated immune responses after measles vaccination.

Authors:  Benjamin J Umlauf; Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Viral Immunol       Date:  2012-01-12       Impact factor: 2.257

2.  Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2011-08-27       Impact factor: 3.641

3.  Response surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells.

Authors:  Matthew J Taylor; Iana H Haralambieva; Robert A Vierkant; Inna G Ovsyannikova; Gregory A Poland
Journal:  J Immunol Methods       Date:  2012-06-13       Impact factor: 2.303

4.  Genome-wide characterization of transcriptional patterns in high and low antibody responders to rubella vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Sumit Middha; Brian M Bot; Vivian W Wang; David I Smith; Robert M Jacobson; Gregory A Poland
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

Review 5.  Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates.

Authors:  I-Ming Wang; Andrew J Bett; Razvan Cristescu; Andrey Loboda; Jan ter Meulen
Journal:  Microb Biotechnol       Date:  2011-11-22       Impact factor: 5.813

Review 6.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

Review 7.  Engineering and combining oncolytic measles virus for cancer therapy.

Authors:  Mathias F Leber; Serge Neault; Elise Jirovec; Russell Barkley; Aida Said; John C Bell; Guy Ungerechts
Journal:  Cytokine Growth Factor Rev       Date:  2020-07-03       Impact factor: 7.638

8.  Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.

Authors:  Iana H Haralambieva; Whitney L Simon; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  Viruses       Date:  2015-03-10       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.